Robert B. Bazemore Jr
2017
In 2017, Robert B. Bazemore Jr earned a total compensation of $3.6M as President and Chief Executive Officer at Epizyme, a 9% increase compared to previous year.
Compensation breakdown
| Bonus | $282,967 |
|---|---|
| Option Awards | $2,748,879 |
| Salary | $556,200 |
| Other | $1,523 |
| Total | $3,589,569 |
Bazemore received $2.7M in option awards, accounting for 77% of the total pay in 2017.
Bazemore also received $283K in bonus, $556.2K in salary and $1.5K in other compensation.
Rankings
In 2017, Robert B. Bazemore Jr's compensation ranked 2,927th out of 14,666 executives tracked by ExecPay. In other words, Bazemore earned more than 80.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,927 out of 14,666 | 80th |
Division Manufacturing | 1,008 out of 5,772 | 83rd |
Major group Chemicals And Allied Products | 269 out of 2,075 | 87th |
Industry group Drugs | 205 out of 1,731 | 88th |
Industry Pharmaceutical Preparations | 163 out of 1,333 | 88th |
Source: SEC filing on April 5, 2018.
Bazemore's colleagues
We found three more compensation records of executives who worked with Robert B. Bazemore Jr at Epizyme in 2017.